Trials / Sponsors / Vanguard Research Group
Vanguard Research Group
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Ph Schizophrenia | Phase 4 | 2025-04-16 |
| Completed | Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cyc Schizophrenia | Phase 4 | 2014-12-11 |